In this randomized , double-blind , double-dummy study , patients received oral edoxaban 30 mg once daily beginning 6 to 24 hours postsurgery or enoxaparin 2000 IU ( equivalent to 20 mg ) subcutaneously twice daily beginning 24 to 36 hours postsurgery for 11 to 14 days .